The FDA has granted approval to the age-related macular degeneration treatment Eylea, clearing the way to provide another form of treatment for the leading eye disease causing blindness in the … [Read more...]
Genetic Mutation Identifies High Risk of Macular Degeneration
November 3, 2011 By 1 Comment
A rare genetic mutation has been identified that predicts a high risk of macular degeneration. Macular degeneration is seen as the leading cause of blindness in the elderly. Having a genetic … [Read more...]
Possible Lucentis Side-Effects Discovered
November 2, 2011 By Leave a Comment
Researchers may have uncovered a side-effect in the macular degeneration treatment Lucentis. Lucentis is the leading treatment for wet macular degeneration. However, researchers at the Mayo … [Read more...]
Daily Aspirin Increases Risk of Macular Degeneration
October 15, 2011 By Leave a Comment
New research has shown seniors taking a daily dose of aspirin are twice as likely to develop late stage macular degeneration than people who don't take the drug. While aspirin does not directly … [Read more...]
Gene Therapy and Stem Cell Therapy for Macular Degeneration
September 23, 2011 By 1 Comment
Macular Degeneration has been identified as a leading cause of blindness and vision loss among older people. Because of better diagnostic techniques in recent years, more and more people are being … [Read more...]
Recent Comments